JP2008513524A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2008513524A5 JP2008513524A5 JP2007532749A JP2007532749A JP2008513524A5 JP 2008513524 A5 JP2008513524 A5 JP 2008513524A5 JP 2007532749 A JP2007532749 A JP 2007532749A JP 2007532749 A JP2007532749 A JP 2007532749A JP 2008513524 A5 JP2008513524 A5 JP 2008513524A5
- Authority
- JP
- Japan
- Prior art keywords
- acid
- release formulation
- sustained release
- sustained
- pharmaceutically
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN200410077961.9 | 2004-09-21 | ||
| CN200410077961 | 2004-09-21 | ||
| PCT/CN2005/001521 WO2006032202A1 (fr) | 2004-09-21 | 2005-09-21 | Formulation à libération lente et prolongée contenant un agoniste du récepteur de la dopamine et son procédé de préparation |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2008513524A JP2008513524A (ja) | 2008-05-01 |
| JP2008513524A5 true JP2008513524A5 (https=) | 2011-04-07 |
| JP5081622B2 JP5081622B2 (ja) | 2012-11-28 |
Family
ID=36089849
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2007532749A Expired - Lifetime JP5081622B2 (ja) | 2004-09-21 | 2005-09-21 | ドーパミン受容体アゴニストを含む長時間作用する持続放出製剤、及びそれらの製造方法 |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US8691277B2 (https=) |
| EP (1) | EP1797871B1 (https=) |
| JP (1) | JP5081622B2 (https=) |
| KR (1) | KR20070059161A (https=) |
| AU (1) | AU2005287743B2 (https=) |
| CA (1) | CA2581143C (https=) |
| ES (1) | ES2536460T3 (https=) |
| PL (1) | PL1797871T3 (https=) |
| WO (1) | WO2006032202A1 (https=) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7435738B2 (en) | 2003-08-18 | 2008-10-14 | Solvay Pharmaceuticals, Inc. | Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate) |
| US7405216B2 (en) | 2004-08-18 | 2008-07-29 | Solvay Pharmaceuticals, B.V. | Stable crystalline form of bifeprunox mesylate (7-[4-([1,1′-biphenyl]-3-ylmethyl)-1-piperazinyl]-2(3H)-benzoxazolone monomethanesulfonate) |
| US7423040B2 (en) | 2005-02-18 | 2008-09-09 | Irene Eijgendaal | Stable crystalline form of bifeprunox mesylate, dosage forms thereof and methods for using same |
| US7964604B2 (en) | 2005-02-18 | 2011-06-21 | Solvay Pharmaceuticals B.V. | Bifeprunox mesylate maintenance dose compositions and methods for using the same |
| ES2402376T3 (es) * | 2006-04-06 | 2013-05-03 | Nupathe Inc. | Implantes para el tratamiento de estados asociados con dopamina |
| US8106056B2 (en) | 2006-06-16 | 2012-01-31 | Solvay Pharmaceuticals B.V. | Combination preparations comprising bifeprunox and a dopamine agonist |
| US7786126B2 (en) | 2006-06-16 | 2010-08-31 | Solvay Pharmaceuticals B.V. | Combination preparations comprising SLV308 and a dopamine agonist |
| JP2009539941A (ja) * | 2006-06-16 | 2009-11-19 | ソルベイ・フアーマシユーチカルズ・ベー・ブイ | Ｓｌｖ３０８およびｌ−ｄｏｐａを含んでなる組み合わせ製剤 |
| TWI392670B (zh) * | 2006-06-22 | 2013-04-11 | Ucb Pharma Gmbh | 經取代的２-胺基萘滿之於製造用於預防、減緩及／或治療各種類型疼痛之藥物上的用途 |
| WO2008009665A1 (en) * | 2006-07-19 | 2008-01-24 | Boehringer Ingelheim International Gmbh | Treatment of pain |
| EP2291178A4 (en) * | 2008-06-09 | 2013-07-24 | Supernus Pharmaceuticals Inc | PRAMIPEXOL FORMULATIONS WITH CONTROLLED RELEASE |
| EP2452677A1 (en) | 2008-09-29 | 2012-05-16 | Wockhardt Limited | Extended release dosage form of ropinirole |
| FR2936710B1 (fr) * | 2008-10-07 | 2011-01-07 | Ceva Sante Animale | Composition veterinaire antiprolactinique destinee aux ruminants |
| AU2010266285A1 (en) * | 2009-07-02 | 2012-02-09 | Supernus Pharmaceuticals, Inc. | A method of treatment of a neurological disorder |
| WO2011012723A1 (en) | 2009-07-31 | 2011-02-03 | Ascendis Pharma As | Injectable sustained release compositions comprising a pramipexole prodrug |
| US20120191039A1 (en) | 2009-07-31 | 2012-07-26 | Ascendis Pharma A/S | Carrier linked pramipexole prodrugs |
| DE102010014113A1 (de) * | 2010-04-07 | 2011-10-13 | Acino Ag | Freisetzungsverfahren für Implantate |
| RU2589700C2 (ru) * | 2010-11-25 | 2016-07-10 | Шан Донг Люие Фармацеутикал Ко., Лтд | Композиции ротиготина, его производных, или фармацевтически приемлемых солей ротиготина или их производных |
| WO2012074988A1 (en) * | 2010-12-02 | 2012-06-07 | Ratiopharm Gmbh | Rotigotine ionic liquid |
| US9956201B2 (en) | 2014-07-21 | 2018-05-01 | Spriaso Llc | Compositions comprising bioreversible derivatives of hydroxy N-substituted-2-aminotetralins, and related dosage forms |
| WO2018096560A1 (en) | 2016-11-23 | 2018-05-31 | Cipla Limited | Long acting depot formulation for the continuous dopaminergic stimulation |
| US20190374534A1 (en) | 2018-06-08 | 2019-12-12 | Boehringer Ingelheim Vetmedica Gmbh | Liquid pharmaceutical compositions comprising pergolide |
| KR102212722B1 (ko) * | 2019-12-23 | 2021-02-08 | 환인제약 주식회사 | 로피니롤을 포함하는 마이크로스피어 및 이를 함유하는 주사제 조성물 |
| WO2025243901A1 (ja) * | 2024-05-21 | 2025-11-27 | 株式会社 SENTAN Pharma | 注射製剤 |
Family Cites Families (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4166800A (en) * | 1977-08-25 | 1979-09-04 | Sandoz, Inc. | Processes for preparation of microspheres |
| JP2651320B2 (ja) * | 1992-07-16 | 1997-09-10 | 田辺製薬株式会社 | 徐放性マイクロスフェア製剤の製造方法 |
| KR20000015944A (ko) * | 1996-05-24 | 2000-03-15 | 팜 윌리암 엔. | 신체 통로의 질병을 치료 또는 예방하기 위한조성물 및 방법 |
| JPH10167968A (ja) * | 1996-10-09 | 1998-06-23 | Takeda Chem Ind Ltd | マイクロパーティクルの製造法 |
| CA2267930A1 (en) | 1996-10-09 | 1998-04-16 | Nobuyuki Takechi | A method for producing a microparticle |
| ATE203157T1 (de) * | 1996-12-20 | 2001-08-15 | Alza Corp | Injizierbare depotgelzubereitung und herstellungsverfahren |
| JP3663271B2 (ja) * | 1997-01-24 | 2005-06-22 | シュバルツ ファルマ アクチェンゲゼルシャフト | 新規の分枝鎖エステル及びその製法 |
| AU752225B2 (en) * | 1998-07-17 | 2002-09-12 | Pacira Pharmaceuticals, Inc. | Biodegradable compositions for the controlled release of encapsulated substances |
| DK1140026T3 (da) * | 1998-12-16 | 2006-01-02 | Aventis Pharma Inc | Serotoninreceptorantagonist indkapslet i biologisk nedbrydelig polymer og fremgangsmåde til fremstilling af samme |
| US6455526B1 (en) * | 1998-12-16 | 2002-09-24 | Aventis Pharmaceuticals, Inc. | Biodegradable polymer encapsulated pharmaceutical compositions and method for preparing the same |
| GB9828861D0 (en) | 1998-12-31 | 1999-02-17 | Danbiosyst Uk | Compositions |
| DE60030828T2 (de) | 1999-07-09 | 2007-02-08 | Bts Holding International Bv | Optische abtastvorrichtung mit umschaltbarer auflösung |
| CA2405205C (en) | 2000-04-28 | 2007-11-20 | Tanabe Seiyaku Co., Ltd. | Method for preparing microspheres |
| DE10041479A1 (de) * | 2000-08-24 | 2002-03-14 | Sanol Arznei Schwarz Gmbh | Neue pharmazeutische Zusammensetzung zur Verabreichung von N-0923 |
| DE10055742B4 (de) * | 2000-11-10 | 2006-05-11 | Schwarz Pharma Ag | Neue Polyester, Verfahren zu ihrer Herstellung und aus den Polyestern hergestellte Depot-Arzneiformen |
| WO2002087586A1 (en) * | 2001-04-26 | 2002-11-07 | Control Delivery Systems, Inc. | Sustained release drug delivery system containing codrugs |
| CN1735404A (zh) * | 2002-11-18 | 2006-02-15 | 波利梅里斯公司 | 使用新聚合物的医疗装置 |
| SI1610791T1 (sl) * | 2003-03-31 | 2011-05-31 | Titan Pharmaceuticals Inc | Implantibilna polimerna naprava za zadržano sproščanje dopaminskega agonista |
| DE10334188B4 (de) * | 2003-07-26 | 2007-07-05 | Schwarz Pharma Ag | Verwendung von Rotigotin zur Behandlung von Depressionen |
-
2005
- 2005-09-21 KR KR1020077008896A patent/KR20070059161A/ko not_active Ceased
- 2005-09-21 CA CA2581143A patent/CA2581143C/en not_active Expired - Fee Related
- 2005-09-21 US US11/663,411 patent/US8691277B2/en active Active
- 2005-09-21 ES ES05792179.3T patent/ES2536460T3/es not_active Expired - Lifetime
- 2005-09-21 AU AU2005287743A patent/AU2005287743B2/en not_active Ceased
- 2005-09-21 EP EP05792179.3A patent/EP1797871B1/en not_active Expired - Lifetime
- 2005-09-21 WO PCT/CN2005/001521 patent/WO2006032202A1/zh not_active Ceased
- 2005-09-21 JP JP2007532749A patent/JP5081622B2/ja not_active Expired - Lifetime
- 2005-09-21 PL PL05792179T patent/PL1797871T3/pl unknown
-
2014
- 2014-03-17 US US14/182,652 patent/US9220782B2/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2008513524A5 (https=) | ||
| EP2968320B1 (en) | Organic compounds | |
| JP5081622B2 (ja) | ドーパミン受容体アゴニストを含む長時間作用する持続放出製剤、及びそれらの製造方法 | |
| CN100563658C (zh) | 苯丙氨酸衍生物的固体分散体或固体分散体医药制剂 | |
| EP2327397A2 (en) | Method for manufacturing sustained release microsphere by solvent flow evaporation method | |
| CN103209704A (zh) | 有机化合物 | |
| WO2014207664A2 (en) | Stable pharmaceutical composition of asenapine | |
| JP2016513721A5 (https=) | ||
| JP2016527308A (ja) | エンテカビル微小球及びこれを含む非経口投与用医薬組成物 | |
| TW201429507A (zh) | 包含作爲活性成分的四唑衍生物之具改良溶解度的固態分散體 | |
| KR101663561B1 (ko) | 서방출성 미립구의 제조방법 | |
| CN113226288B (zh) | 纳曲酮注射型缓释制剂 | |
| CN1762495B (zh) | 含有多巴胺受体激动剂类药物的长效缓释制剂及其制备工艺 | |
| CN115942935B (zh) | 包括氯胺酮的微球制剂及其制备和使用方法 | |
| KR20230036886A (ko) | 생분해성 고분자를 이용한 서방형 미립구 및 이의 제조방법 | |
| CA3236690A1 (en) | Sustained-release injectable composition containing naltrexone and method for preparing same | |
| KR102793673B1 (ko) | 바리시티닙을 포함하는 장기지속형 미립구의 제조 방법 및 이의 제조 방법으로 제조된 바리시티닙을 포함하는 장기지속형 미립구 | |
| WO2006066509A1 (fr) | Préparation microsphérique à libération prolongée injectable de dérivés de 3,3-diphénylpropylamine servant d'antagonistes du récepteur muscarinique | |
| CN1857220B (zh) | 一种抗结核病药物缓释剂 | |
| WO2025101020A1 (ko) | 패티게이션 기술을 적용한 쿠에티아핀-지방산 접합체 나노입자 및 이의 장기 지속형 주사제 용도 | |
| KR20230032772A (ko) | 아픽사반을 함유하는 서방성 미립구 | |
| HK40047988A (en) | Naltrexone injectable sustained release formulation | |
| JPWO2001005795A1 (ja) | 頻尿もしくは尿失禁の治療または予防剤 |